These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25748296)

  • 1. The metabolic syndrome in a memory clinic population: relation with clinical profile and prognosis.
    Exalto LG; van der Flier WM; van Boheemen CJM; Kappelle LJ; Vrenken H; Teunissen C; Koene T; Scheltens P; Biessels GJ
    J Neurol Sci; 2015 Apr; 351(1-2):18-23. PubMed ID: 25748296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome and cognitive decline in the elderly: A systematic review.
    Assuncao N; Sudo FK; Drummond C; de Felice FG; Mattos P
    PLoS One; 2018; 13(3):e0194990. PubMed ID: 29579115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.
    Ng TP; Feng L; Nyunt MS; Feng L; Gao Q; Lim ML; Collinson SL; Chong MS; Lim WS; Lee TS; Yap P; Yap KB
    JAMA Neurol; 2016 Apr; 73(4):456-63. PubMed ID: 26926205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between depressive symptoms and cognitive impairment in patients with metabolic syndrome.
    Kopchak O; Pulyk O
    Wiad Lek; 2017; 70(4):737-741. PubMed ID: 29064796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of subjective memory complaints in the clinical setting.
    Silva D; Guerreiro M; Faria C; Maroco J; Schmand BA; Mendonça Ad
    J Geriatr Psychiatry Neurol; 2014 Dec; 27(4):259-65. PubMed ID: 24763068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study.
    Tondelli M; Bedin R; Chiari A; Molinari MA; Bonifacio G; Lelli N; Trenti T; Nichelli P
    Clin Chem Lab Med; 2015 Feb; 53(3):453-60. PubMed ID: 25274948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies.
    Atti AR; Valente S; Iodice A; Caramella I; Ferrari B; Albert U; Mandelli L; De Ronchi D
    Am J Geriatr Psychiatry; 2019 Jun; 27(6):625-637. PubMed ID: 30917904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age related characteristics of cognitive changes in patients with metabolic syndrome.
    Bezrukov VV; Bachinskaya NY; Kopchak OO; Kholin VO; Pulyk OR
    Wiad Lek; 2018; 71(8):1515-1523. PubMed ID: 30684334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cognitive Assessment Battery (CAB): a rapid test of cognitive domains.
    Nordlund A; Påhlsson L; Holmberg C; Lind K; Wallin A
    Int Psychogeriatr; 2011 Sep; 23(7):1144-51. PubMed ID: 21251350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging.
    Solfrizzi V; Scafato E; Capurso C; D'Introno A; Colacicco AM; Frisardi V; Vendemiale G; Baldereschi M; Crepaldi G; Di Carlo A; Galluzzo L; Gandin C; Inzitari D; Maggi S; Capurso A; Panza F;
    Neurobiol Aging; 2011 Nov; 32(11):1932-41. PubMed ID: 20045217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
    Mazzeo S; Santangelo R; Bernasconi MP; Cecchetti G; Fiorino A; Pinto P; Passerini G; Falautano M; Comi G; Magnani G
    J Alzheimers Dis; 2016 Oct; 54(4):1495-1508. PubMed ID: 27589522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke.
    Stephens S; Kenny RA; Rowan E; Allan L; Kalaria RN; Bradbury M; Ballard CG
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1053-7. PubMed ID: 15481073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: the Hoorn Study.
    Reijmer YD; van den Berg E; Dekker JM; Nijpels G; Stehouwer CD; Kappelle LJ; Biessels GJ
    Atherosclerosis; 2011 Dec; 219(2):839-45. PubMed ID: 21959256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alabama Brief Cognitive Screener: Utility of a New Cognitive Screening Instrument in a Memory Disorders Clinic.
    Love MCN; Pilonieta G; Geldmacher DS
    Prim Care Companion CNS Disord; 2019 Mar; 21(2):. PubMed ID: 30896091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome and Cognitive Impairment among High Socioeconomic, Nondemented Older US Adults.
    Martinez-Miller EE; Kohl HW; Barlow CE; Willis BL; DeFina LF
    J Am Geriatr Soc; 2019 Jul; 67(7):1437-1443. PubMed ID: 30854644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.